Research analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on the software maker’s stock.
Separately, Stephens lifted their price objective on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
Read Our Latest Analysis on MDRX
Veradigm Trading Down 0.5 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- 3 Stocks to Consider Buying in October
- How to Protect Your Portfolio When Inflation Is Rising
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- 3 Fintech Stocks With Good 2021 Prospects
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
